UnknownPHASE2, PHASE3NCT01747278

Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients

Studying Pneumocystosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Peking Union Medical College Hospital
Principal Investigator: Fengchun Zhang, MD, MD
Peking Union Medical College Hospital
Intervention: Trimethoprim/Sulfamethoxazole(drug)
Enrollment: 80 target
Eligibility: 18-65 years · All sexes
Timeline: 2012 – 2013

Study locations (1)

Deptment of Rheumatology, Peking Union Medical College Hospital, Beijing, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01747278 on ClinicalTrials.gov

Other trials for Pneumocystosis

Additional recruiting or active studies for the same condition.

See all trials for Pneumocystosis →

← Back to all trials